Skip to main content

Addiction Now: Safe Injection Facilities as a Public Health Strategy

  • When
  • May 18, 2017
    2:00–8:00 p.m. (EDT)
  • Where
  • Maryland Art Place, 218 W Saratoga Street, Baltimore, MD 21201
  • Speakers
  • Sarah Evans, Greg Hobelmann, Simone Speed, and Clarence Brown
  • In partnership with
  • New Day Campaign

Please join Open Society Institute–Baltimore, in collaboration with the New Day Campaign, for a discussion about how safe injection facilities reduce overdoses and increase access to treatment by allowing people who use drugs to inject opioids in a medical setting. How does this fit into a broader harm reduction strategy? What kind of public education and stigma reduction could make this solution more possible, less controversial?

Participants include Sarah Evans, a former coordinator of Vancouver’s Insite, North America’s first and only legal supervised drug injection facility; Dr. Greg Hobelmann, a physician at Baltimore’s Ashley Addiction Treatment; singer Simone Speed; author Clarence Brown; and clients of Powell Recovery Center, whose testimonials underscore the dangers of unsupervised drug use.

At the opening of the event, the Baltimore Harm Reduction Coalition will lead a 10-minute opioid overdose response training, after which attendees will receive a naloxone kit that makes it possible to save someone’s life from an opioid overdose.

Speakers

  • Sarah Evans

    Speaker

    Sarah Evans is a senior program manager with the Open Society Public Health Program and former coordinator of Vancouver’s Insite.

  • Greg Hobelmann

    Speaker

    Dr. Greg Hobelmann is a physician at Baltimore’s Ashley Addiction Treatment.

  • Simone Speed

    Speaker

    Simone Speed is a singer.

  • Clarence Brown

    Speaker

    Clarence Brown is an author.

Read more

Subscribe to updates about upcoming Open Society events

By entering your email address and clicking “Submit,” you agree to receive updates from the Open Society Foundations about our work. To learn more about how we use and protect your personal data, please view our privacy policy.